National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
76.42
-0.13 (-0.17%)
May 22, 2026, 4:00 PM EDT - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, National Health Investors stock has a consensus rating of "Buy" and an average price target of $87.13. The average 1-year stock price forecast is 14.01% higher than the current stock price, while the lowest is $74 (-3.17%) and the highest is $97 (+26.93%).
Price Target: $87.13 (+14.01%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 22, 2026.
Analyst Ratings
The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $86 → $84 | Hold | Maintains | $86 → $84 | +9.92% | Apr 22, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $94 | Buy | Reiterates | $94 | +23.00% | Apr 22, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $92 → $89 | Strong Buy | Maintains | $92 → $89 | +16.46% | Apr 22, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $85 → $86 | Hold | Maintains | $85 → $86 | +12.54% | Mar 27, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $85 → $92 | Strong Buy | Maintains | $85 → $92 | +20.39% | Mar 12, 2026 |
Financial Forecast
Revenue This Year
432.48M
from 379.29M
Increased by 14.02%
Revenue Next Year
466.68M
from 432.48M
Increased by 7.91%
EPS This Year
3.63
from 3.02
Increased by 20.06%
EPS Next Year
3.49
from 3.63
Decreased by -3.71%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 452.6M | 492.0M | ||||
| Avg | 432.5M | 466.7M | ||||
| Low | 413.5M | 448.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 19.3% | 13.8% | ||||
| Avg | 14.0% | 7.9% | ||||
| Low | 9.0% | 3.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.64 | 3.82 | |
| Avg | 3.63 | 3.49 | |
| Low | 3.07 | 3.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 53.7% | 5.4% | |
| Avg | 20.1% | -3.7% | |
| Low | 1.6% | -11.9% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.